Rare Disease 360™ is part of the International Healthcare Media (IHM) Family of Media Brands. IHM is a global communications media company that engages healthcare professionals, patients and patient advocates through live events, print brands, websites, videos/podcasts, and proprietary digital media assets. IHM helps clinicians deliver quality care, improve patient outcomes and satisfaction, and optimize quality along the continuum of care through brands that target specific clinicians, diseases, and conditions. Using its international reach and access to key thought leaders around the globe, IHM delivers an audience of engaged healthcare professionals by providing clinicians with succinct practical recommendations. Its brands include Ophthalmology 360® | ophthalmology360.com, the year-round, multi-content-award-winning platform relied upon by eyecare providers and other specialists; The Ophthalmic Blog™, which has scored a multitude of key interviews with leading industry experts and is produced & published by industry Rockstar Mark Dlugoss; and Rare Disease 360™ | rd-360.com, the go-to resource and platform for rare disease content.